We studied interactions in vitro between human granulocytes and the yeastlike form of Blastomyces dermatitidis, because granulocytes are prominent in the host response to systemic blastomycosis. In Boyden chamber assays, broth culture filtrates of B. dermatitidis contained levels of granulocyte chemotactic activity that were significantly higher than those present in similar culture filtrates of Histoplasma capsulatum and Cryptococcus neoformans, two fungi that characteristically do not elicit granulocytes in infected tissues. Microscopic study, including electron microscopy, demonstrated that granulocytes phagocytosed B. dermatitidis promptly and efficiently. Moreover, granulocytes emitted light (chemiluminescence) at a brisk rate during phagocytosis of B. dermatitidis, indicating activation of intracellular metabolic pathways. However, fungicidal assays showed that granulocytes (1:1 cell-yeast ratio, 10% serum) killed only 29% of the B. dermatitidis inoculum during 3 h of incubation. Taken together, these findings suggest that there is disparity between phagocytosis and intracellular killing of B. dermatitidis by human granulocytes, perhaps because of resistance of this fungus to granulocyte microbicidal mechanisms.
The host response to Blastomyces dermatitidis, the dimorphic fungus that causes systemic blastomycosis, is characteristically suppurative as well as granulomatous; infected tissues are usually infiltrated by granulocytes (4, 8) . Despite this consistent observation, there is only limited infonnation (21) on the capability of the human granulocyte to contribute to host defense against this fungus. The present study was designed to examine interactions in vitro between human granulocytes and the yeastlike phase of B. dermatitidis, which is the form of the fungus found in human tissues. Specific granulocyte functions that were studied represent sequential steps in the process by which granulocytes locate and kill invading microbes: chemotaxis, phagocytosis, metabolic activation, and intracellular killing (19 Samples were processed and stained as previously described (20) . Electron micrographs were taken on a Siemens 101 electron microscope.
RESULTS
Chemotazis studies. The broth culture supernatant of the experimental strain B. dermatitidis contained granulocyte chemotactic activity that was significantly greater than that demonstrated in supernatants of C. neoformans and H. capsulatum (Table 1) .
Chemiluminescence. Granulocytes interacting with B. dermatitidis emitted light at a brisk rate (Fig. 1) . Granulocyte chemiluminescence stimulated by B. dermititidis was less than that invoked by zymosan, but more than that caused by S. aureus under the conditions employed. An additional study using granulocytes from another donor gave similar results (peak, 2.76 x 'Level of significance of difference (P) from mean counts per minute of other fungal culture supernatants. NS, Not significant. Fungicidal studies. Exposure of B. dermatitidis to granulocytes (1:1 ratio) and 10% serum for 3 h resulted in a mean reduction in colonyforming units of 29% (Fig. 2) . The results of preparations containing one fungus to 10 granulocytes were similar. Serum concentrations higher than 10% resulted in no significant augmentation of killing (20 and 40% serum gave 31
and 36% reduction in colony-forming units
[CFU], respectively); however, in the absence of serum there was no reduction in CFU. There was no enhancement of granulocyte fungicidal activity when normal serum was replaced by convalescent serum (19% CFU reduction at 1:1 granulocyte:yeast ratio, mean of five experiments).
DISCUSSION These experiments show that human granulocytes respond to B. dermatitidis as they do to pyogenic bacteria. First, granulocytes were highly stimulated by chemotactic factors elaborated by B. dermatitidis during growth in broth culture. Several types of bacteria and C. albicans produced granulocyte chemotactic factors during growth (5, 20, 22) It is not surprising that the susceptibility of fungi to granulocyte microbial mechanisms is different than that of bacteria. For example, their cell walls are distinctly different with respect to ultrastructure, biochemical content, and resistance to changes in pH (13) . Other investigators are now studying novel mechanisms by which granulocytes act against fungi, including extracellular killing (3, 6, 7, 11) ; these techniques need to be applied to the study of B. dermatitidis.
The clinical implications of this study deserve comment. On the one hand, the abundance of granulocytes in tissues invaded by B. dermatitidis (4, 8) could be related to the production of chemotactic factors by the fungus. However, in view of the apparent ease with which granulocytes phagocytose B. dernatitidis, it is somewhat surprising that the yeastlike forms are rarely found within granulocytes in tissue sections. Finally, it is tempting to speculate that the relative resistance of B. dermatitidis to intracellular killing by human granulocytes is somehow related to the relentless progression of untreated systemic blastomycosis (12) .
